Micro
Developing
Active
LLY's retatrutide shows mixed trial results
Score
0.4
Velocity
▲ 1.0
Articles
6
Sources
2
Summary
An article belongs to this narrative if it discusses Eli Lilly and Company's (LLY) retatrutide's mixed trial results for type 2 diabetes treatment.
Related Articles
Jim Cramer Believes Eli Lilly’s “Weight Loss Pill Will Be a Blockbuster”
Yahoo Finance
·
Apr 05, 2026
Should You Buy Eli Lilly Stock Before April 10?
Nasdaq
·
Mar 22, 2026
Eli Lilly and Company (LLY) Announces Positive Topline Results From the Phase 3 ADorable-1 Trial
Yahoo Finance
·
Mar 22, 2026
RBC Capital Sees Eli Lilly’s (LLY) Retatrutide as Key Growth Driver despite Mixed Trial Results
Yahoo Finance
·
Mar 21, 2026
Sources
Timeline
Last Updated
Mar 21, 2026